We were able to show that Jass groups 1 and 2 definitely represent serrated adenocarcinomas, but KRAS-mutated cases belonging to Jass group 3 were composed of serrated and non-serrated cancers. The gene discussed is KRAS; the disease is adenocarcinoma.